Menu Close

Autologous Cell Therapy Market Will Cross US$23.7 Bn by 2024

Albany, NY — (SBWIRE) — 07/30/2018 — In the past few decades, the field of autologous cell therapy (ACT) has been witnessed rapid evolution and a surge in research activities aimed at the realization of the potential benefits of use of biosynthetic …

Date : 2018-07-30T20:52:00.000Z
Source : http://www.digitaljournal.com/pr/3876229